Related Experiment Video

Updated: May 18, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Vertical pathway targeting in cancer therapy

David Shahbazian1, Joshua Sznol, Harriet M Kluger

  • 1Section of Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.

Advances in Pharmacology (San Diego, Calif.)
|September 11, 2012
PubMed

Insights

Targeting cancer

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Malignant cells develop from genetic mutations affecting cell growth and survival.
  • Traditional chemotherapy targets rapidly dividing cells, causing significant side effects.
  • Targeted therapies focus on specific oncogenes driving cancer growth.

Purpose of the Study:

  • To review strategies for multitarget inhibition in cancer therapy.
  • To emphasize vertical signaling pathway targeting for enhanced efficacy.
  • To address limitations of single oncogene targeting in solid tumors.

Main Methods:

  • Review of current cancer research and drug development strategies.
  • Analysis of signaling networks in solid tumors.
  • Discussion of parallel versus vertical targeting approaches.

Main Results:

  • Single oncogene targeting often proves insufficient due to tumor resistance mechanisms.
  • Drug combinations are essential for improving growth inhibition and cytotoxicity.
  • Vertical targeting offers a promising strategy by hitting multiple points in a single pathway.

Conclusions:

  • Multitarget inhibition, particularly vertical targeting, is crucial for overcoming resistance and improving cancer treatment outcomes.
  • Future cancer therapies will likely rely on sophisticated drug combinations.
  • Understanding cancer signaling networks is key to designing effective targeted treatments.

More Related Videos

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...